Understanding the N/P Ratio in mRNA-LNP Complexes

Understanding the N/P Ratio in mRNA-LNP Complexes

Sunday, July 7, 2024

N/P molar ratio

The N/P ratio is crucial in transfection, especially with mRNA and lipid nanoparticles (LNPs). This ratio, representing nitrogen to phosphate, significantly impacts nanoparticle properties such as size and encapsulation efficiency.

What is the N/P Ratio?

The N/P ratio indicates the molar ratio between the amine groups (N) of the ionizable lipid and the phosphate groups (P) of the cargo. For RNA, there's one phosphate group per base, and for DNA, there are two phosphate groups per base. Typical N/P ratios range from three to six, varying with the cargo and ionizable lipid used. Notably, Pfizer and Moderna use a 6:1 N/P ratio in their mRNA vaccine formulations.

How to Calculate the N/P Ratio

Calculate your N/P ratio 

Significance of the N/P Ratio

Optimizing the N/P ratio is vital as it influences LNP efficiency. A higher N/P ratio generally results in nanoparticles with more positive charges, enhancing interaction with negatively charged cell membranes, potentially increasing transfection efficiency and affecting cytotoxicity.

References:

  1. Maier, M. A., et al. (2019). Biochemistry and pharmacology of mRNA. Mol Ther.
  2. Payload distribution and capacity of mRNA lipid nanoparticles. ResearchGate.
  3. The effect of lipid nanoparticles on mRNA delivery and biodistribution. ScienceDirect.
  4. Recent advances in lipid nanoparticle formulations for mRNA delivery. PMC.

Written by

Marija Petrovic

Marija Petrovic is a nanomedicine professional with over seven years of experience in the field. She earned her PhD in Biopharmacy from the University of Geneva, where she worked in Gerrit Borchard’s lab on formulating STING ligand nanocomplexes. Marija’s expertise includes formulation, analytics, physico-chemical characterization, and in vitro and in vivo analysis. She is also JRC EU NCL certified for nanobiotechnology, reflecting her commitment to overcoming challenges in nanomedicine characterization (DLS, AF4, AUC, NTA, SEM, TEM..).Recognized by Innosuisse Startup Formation with two prizes for the best life science project on nanocharacterization, Marija also serves as the Communication Chair for the Gene Delivery and Editing Group at the Controlled Release Society (CRS) and as the founder of NanoSphere, acting as a key channel for scientific communication in nanomedicine.

NanoSphere ChatGPT

Explore this prompt to quickly get acquainted with the fascinating world of nanomedicine

About

Sign up for our newsletter to stay informed with the latest insights and updates!

Follow Us

Search